Status:
COMPLETED
Breast Cancer in Poland: An Expanded Study to Assess Occupational and Environmental Factors and Interactions With Genetics
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Ovarian Neoplasms
Endometrial Neoplasms
Eligibility:
FEMALE
20-74 years
Brief Summary
The Polish breast, ovarian and endometrial cancer study is a complex molecular epidemiologic study that is expected to enroll about 2,500 breast cancer, 450 ovarian and 450 endometrial cancer cases an...
Detailed Description
The Polish breast, ovarian and endometrial cancer study is a complex molecular epidemiologic study conducted in two major cities in Poland (Warsaw and Lodz) that enrolled 2,386 breast cancer cases and...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Cases for study will consist of all women ages 20-74 years who are newly diagnosed with either histologically or cytologically confirmed in situ or invasive breast cancers during the two and a half year study period.
- In both Warsaw and Lodz, controls will be selected using the Polish Electronic System of Population Evidence localized in Warsaw (PESEL).
Exclusion
Key Trial Info
Start Date :
September 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 16 2020
Estimated Enrollment :
6086 Patients enrolled
Trial Details
Trial ID
NCT00341458
Start Date
September 1 1999
End Date
April 16 2020
Last Update
April 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Nofer Institute of Occupational Medicine
Lodz, Poland
2
Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology
Warsaw, Poland